A Phased-Implementation Feasibility and Proof-of-Concept Study to Assess Incorporating the NIDA CTN Common Data Elements (CDEs) Into the Electronic Health Record (EHR) in Large Primary Care Settings ("CDE-EHR-PC" Study), Phase 3
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02963948|
Recruitment Status : Completed
First Posted : November 15, 2016
Last Update Posted : January 13, 2020
This is a 4-phase study to implement the NIDA CDEs in primary care settings. Collecting and utilizing the CDEs in clinical practice requires a strategy for implementing screening to collect substance use information that populates the CDEs, and assisting primary care medical staff to offer appropriate interventions by providing clinical decision support (CDS) and a mechanism for making referrals to addiction treatment. Investigators aim to maximize the efficient adoption of screening, CDS, and treatment referrals by integrating all of these activities into the electronic health record (EHR).
The study will be conducted at three sites, representing three large health systems. Each phase will include deliverables essential to move to the next phase, and an independent Advisory Committee will review progress and make recommendations at each transition about how best to progress to each subsequent phase. Based on progress during earlier phases, the Advisory Committee may recommend expansion to additional clinics or health systems during the second part of Phase 4.
|Condition or disease||Intervention/treatment|
|Substance Abuse||Behavioral: Meetings with implementation leader(s) Behavioral: the SAAS survey Behavioral: Patient surveys|
- To program the NIDA CTN CDEs, the NIDA/ASAM electronic Clinical Quality Measure (eCQM), and a lean decision support module into Epic.
- To study the process of implementation of screening and referral using Epic-driven CDEs and CDS in three primary care clinics / practices, including defining potential barriers and facilitators to their adoption.
To evaluate the impact of implementation on:
- Patient level outcomes (diagnosis, treatment referral);
- Medical staff level outcomes (screening and assessment, clinical interventions including counseling and treatment referral); and
- Systems level outcomes (logistics and costs of introducing the CDEs, feasibility).
|Study Type :||Observational|
|Actual Enrollment :||520 participants|
|Official Title:||A Phased-Implementation Feasibility and Proof-of-Concept Study to Assess Incorporating the NIDA CTN Common Data Elements (CDEs) Into the Electronic Health Record (EHR) in Large Primary Care Settings ("CDE-EHR-PC" Study), Phase 3|
|Actual Study Start Date :||February 28, 2018|
|Actual Primary Completion Date :||September 9, 2019|
|Actual Study Completion Date :||September 9, 2019|
Approximately 40 medical staff will be enrolled for the focus groups
Behavioral: Meetings with implementation leader(s)
The perceived appropriateness of the intervention to medical staff will affect an intervention's initial adoption as well as sustainability. We will assess this through focus groups with staff, conducted approximately 1-2 months after implementation of the screening and CDS tools.
Medical staff surveyed using SAAS
Approximately 100 medical staff will be surveyed using the Substance Abuse Attitude Survey (SAAS)
Behavioral: the SAAS survey
Medical staff will be surveyed using the Substance Abuse Attitude Survey (SAAS) to gather information about attitudes from medical staff who do not participate in the focus groups, or may be uncomfortable sharing negative attitudes in a group of their peers. The SAAS is a validated multidimensional instrument that evaluates physician attitudes toward substance-using patients. It includes specific measures of attitudes toward permissiveness, treatment intervention, stereotypes, treatment optimism, and moralism, and has been used in prior studies of primary care physicians. Collecting information on staff attitudes toward substance users and substance use interventions will be helpful to inform about any sources for low adoption of the tools, and any needs for additional provider education and training.
Wave 1 Patients
Approximately 200 patients at a Wave 1 clinic
Behavioral: Patient surveys
Patient surveys regarding attitudes toward substance use screening and interventions in the primary care clinic will be distributed to patients presenting for care, regardless of whether they completed screening, at regular time periods throughout this study phase. The survey will be conducted for 1 week at the following approximate intervals following successful implementation: 1 month, 4 months, 7 months, and 10 months
- Adoption of screening [ Time Frame: 12 Months ]% patients presenting for primary care visits who were screened in the past 12 months
- Provider adoption of CDS [ Time Frame: 12 Months ]% patients with positive screens for which CDS was launched and completed
- Referral of high risk patients [ Time Frame: 12 Months ]% patients with high risk use who received referral to specialty care
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02963948
|United States, Massachusetts|
|Massachusetts General Hospital|
|Boston, Massachusetts, United States, 02114|
|United States, New York|
|Icahn School of Medicine at Mount Sinai|
|New York, New York, United States, 10029|
|Principal Investigator:||Jennifer McNeely, PhD||New York University Medical School|